Novel alternative transplantation therapy for orthotopic liver transplantation in liver failure: A systematic review

doi:10.5500/wjt.v10.i3.64

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7154)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

465

WORD

191

HTML

3695

Figures (1-1)

242

Tables (1-4)

614

Sum=5207

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

719

Download

1228

Sum=1947

Mar 31, 2020 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Transplant. Mar 31, 2020; 10(3): 64-78
Published online Mar 31, 2020. doi: 10.5500/wjt.v10.i3.64

Table 1 Cell transplantation

Donor			*Recipients (disease, strain etc.)*	Outcomes	Year
Cells	Species	Treatments [co-culture (Co), organoid generated]	*Recipients (disease, strain etc.)*	Outcomes	Year
Hepatocytes	Human	-	Human (ALF)	Hepatic function	2018[13]
		-	Human (ACLF)	Hepatic function	2014[22]
		-	Human (metabolic disease)	Engraftment, hepatic function	2012[23]
		-	Human (oxalosis)	Hepatic function	2012[24]
		-	Rat (SD)	Hepatic function, survival extension	2017[25]
		-	Mouse (NOD/SCID)	Alb secretion, engraftment	2017[26]
		-	Mouse (FRG)	Engraftment, hepatic function	2013[27]
		-	Mouse (SCID/Alb-uPA)	Analysis of NK cell	2010[28]
		UC-MSC (human)	Mouse (BALB/c)	Engraftment, hepatic function	2018[29]
	Rat	-	Mouse (C57BL/6 FRG)		2018[30]
		-	Rat (Wistar)	Engraftment	2015[31]
		-	Rat (SD)	Engraftment, hepatic function	2015[32]
		-	Rat	Engraftment	2014[33]
		-	Rat (DPP4-)	Engraftment, repopulation	2014[34]
		-	Rat (An alb)	Engraftment, hepatic function	2014[35]
		HSCs (Rat), SECs (Rat)/Co	Mouse (C57BL/6)	Engraftment, survival extension	2014[36]
		-	Rat (SD)	Hepatic function	2010[37]
	Mouse	Organoid	Mouse (C57BL/6)	Engraftment	2017[38]
		-	Mouse (emdr2^−/−)	Engraftment, Repopulation	2015[39]
		-	Mouse (Fah-/-)	Hepatic function	2010[40]
		-	Mouse (FVB/N)	Engraftment, analysis of metabolite	2010[41]
		-	Mouse (C57BL/6)	Engraftment	2010[42]
Hepatocytes (fetal)	Rat	-	Rat (DPPIV^-)	Engraftment, repopulation	2018[43]
Hepatocytes (fetal)	Mouse	-	Mouse (C57BL/6)	Engraftment, hepatic function	2012[44]
Liver cells	Rabbit	-	Rabbit (New Zealand)	Hepatic function	2012[45]
Hepatic oval cells	Rat	-	Rat (Lewis)	Hepatic function, survival extension	2013[46]
Hepatoma cell line		-	Rat (SD)	Hepatic function, survival extension	2013[47]
UC-MSCs	Human	-	Human after OLT	Hepatic function, intervention rate	2017[48]
UC-MSCs	Human	-	Human after OLT	Hepatic function	2017[49]
BM-MSCs/BM-MNCs	Human	-	Human (LC)	Hepatic function	2017[50]
		-			2016[51]
		-	Human (Liver failure)	Hepatic function	2013[52]
	Rabbit	-	Rabbit	Remodeling	2011[53]
BM-MSCs/HSCs	Human	-	Human (EPP)	Engraftment	2010[54]
BM-MSC	Human	-	Human (LC)	Engraftment, hepatic function	2011[55]
		-	Rat (Wistar)	Hepatic function	2014[56]
		-	Mouse (SCID)	Engraftment, analysis of glucose	2017[57]
		-	Mouse (Pfp/Rag2^−/−)	Engraftment	2010[58]
	Rhesus macaque	-	Mouse	Hepatic function	2018[59]
	Rat	-	Rat (SD)	Hepatic function	2014[60]
BM-MNC-EPC	Rat	-	Rat (SD)	Remodeling	2012[61]
Liver-MSCs	Human	-	Mouse (NOD/SCID)	Engraftment, repopulation	2011[62]
AD-MSCs	Human	-	Mouse (c57/B6)	Analysis of IRI	2014[63]
AD-MSCs	Mouse	-	Mouse (Swiss CD1)	Repopulation	2012[64]
AD-MSC-Hep	Mouse	-	Mouse (C57BL/6)	Engraftment	2015[65]
CD34+ cells	Human	-	Human (LC)	Hepatic function	2015[66]
ESCs-Hep	Mouse	-	Mouse (BALB/c)	Engraftment, hepatic function	2012[67]
iPSC-Hep	Human	Organoid	Mouse (Alb-Tk-NOG)	Survival extension, hepatic function	2017[68]
	Human	Organoid	Mouse (NOD/SCID)	Engraftment	2013[69]
	Mouse	-	Mouse (Fah-/- C57Bl/6)	Engraftment	2010[70]
iMPC-Hep	Human	-	Mouse (FRG)	Engraftment	2014[71]
GPSCs-Hep	Mouse	-	Mouse (Hfe-null)	Engraftment	2015[72]
Liver stem cells	Rat	Organoid	Rat (Fah^−/−Il2rg^−/−)	Engraftment, hepatic function	2016[73]

“-” means negative treatment. ALF: Acute liver failure; ACLF: Acute on chronic liver failure; SD: Sprague dawley; UC-MSCs: Umbilical cord deriver mesenchymal stem cells; BM-MSCs: Bone marrow derived mesenchymal stem cells; MNCs: Mononuclear cells; HSCs: Hematopoietic stem cells; LC: Liver cirrhosis; EPP: Erythropoietic protoporphyria; BM-MNC-EPC: BM-MNC derived endothelial progenitor cell; AD-MSCs: Adipose derived MSCs; IRI: Ischemia-reperfusion injury; AD-MSC-Hep: AD-MSC derived hepatocyte; iMPC: Induced multipotent progenitor cell; GPSCs: Germ line cell-derived pluripotent stem cells.

Citation: Furuta T, Furuya K, Zheng YW, Oda T. Novel alternative transplantation therapy for orthotopic liver transplantation in liver failure: A systematic review. World J Transplant 2020; 10(3): 64-78
URL: https://www.wjgnet.com/2220-3230/full/v10/i3/64.htm
DOI: https://dx.doi.org/10.5500/wjt.v10.i3.64